1 / 22

Presented By Olivia Pagani at 2014 ASCO Annual Meeting

Randomized Comparison of Adjuvant Aromatase Inhibitor <br />Exemestane plus Ovarian Function Suppression<br /> vs Tamoxifen plus Ovarian Function Suppression<br />in Premenopausal Women <br />with Hormone Receptor Positive Early Breast Cancer: <br />Joint Analysis of IBCSG TEXT and SOFT.

rowa
Télécharger la présentation

Presented By Olivia Pagani at 2014 ASCO Annual Meeting

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Randomized Comparison of Adjuvant Aromatase Inhibitor <br />Exemestane plus Ovarian Function Suppression<br /> vs Tamoxifen plus Ovarian Function Suppression<br />in Premenopausal Women <br />with Hormone Receptor Positive Early Breast Cancer: <br />Joint Analysis of IBCSG TEXT and SOFT Presented By Olivia Pagani at 2014 ASCO Annual Meeting

  2. TEXT and SOFT Presented By Olivia Pagani at 2014 ASCO Annual Meeting

  3. TEXT and SOFT Worldwide Collaborative Presented By Olivia Pagani at 2014 ASCO Annual Meeting

  4. Premenopausal Endocrine Therapy Presented By Olivia Pagani at 2014 ASCO Annual Meeting

  5. TEXT - SOFT Trials<br />Aromatase Inhibitor Question Presented By Olivia Pagani at 2014 ASCO Annual Meeting

  6. TEXT and SOFT Designs Presented By Olivia Pagani at 2014 ASCO Annual Meeting

  7. Eligibility Presented By Olivia Pagani at 2014 ASCO Annual Meeting

  8. Treatments Presented By Olivia Pagani at 2014 ASCO Annual Meeting

  9. Study Procedures Presented By Olivia Pagani at 2014 ASCO Annual Meeting

  10. Endpoints Presented By Olivia Pagani at 2014 ASCO Annual Meeting

  11. Statistical Considerations Presented By Olivia Pagani at 2014 ASCO Annual Meeting

  12. Characteristics Presented By Olivia Pagani at 2014 ASCO Annual Meeting

  13. Exemestane+OFS Improved DFS Presented By Olivia Pagani at 2014 ASCO Annual Meeting

  14. Sites of First Failure Presented By Olivia Pagani at 2014 ASCO Annual Meeting

  15. Exemestane+OFS Reduced Recurrence Presented By Olivia Pagani at 2014 ASCO Annual Meeting

  16. Women Who Did Not Receive Chemotherapy Presented By Olivia Pagani at 2014 ASCO Annual Meeting

  17. Women Who Received Chemotherapy Presented By Olivia Pagani at 2014 ASCO Annual Meeting

  18. Selected Adverse Events Presented By Olivia Pagani at 2014 ASCO Annual Meeting

  19. Adverse Events and QOL Presented By Olivia Pagani at 2014 ASCO Annual Meeting

  20. Conclusions Presented By Olivia Pagani at 2014 ASCO Annual Meeting

  21. More from TEXT and SOFT Presented By Olivia Pagani at 2014 ASCO Annual Meeting

  22. Slide 22 Presented By Olivia Pagani at 2014 ASCO Annual Meeting

More Related